Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Norris Medicines Ltd has informed the stock exchange that the trading window for dealing in its securities will be closed from Wednesday, 1st April 2026, in line with the company's Code of Conduct under SEBI's Insider Trading Regulations, 2015. The restriction applies to all designated persons, including promoters, directors, auditors, key managerial personnel, and their immediate relatives. The trading window will reopen 48 hours after the audited financial results for the quarter and year ended 31st March 2026 are publicly declared. The board meeting date to approve these audited results will be communicated separately. This is a standard compliance filing done ahead of the annual financial results announcement.
This is a routine regulatory filing with no direct impact on the stock price. However, it signals that audited annual and Q4 FY26 results are imminent, which could be a catalyst for stock movement once announced. Investors should watch for the upcoming board meeting intimation for the results date.